Expanding Aging Population Worldwide Driving Demand for Minimally Invasive Anti-aging Treatments Utilizing Botulinum Toxin
Rockville , Jan. 24, 2024 (GLOBE NEWSWIRE) -- The global botulinum toxin market is estimated at US$ 6.83 billion in 2024 and is forecasted to expand at a noteworthy 6.8% CAGR from 2024 to 2034. This study by Fact.MR, a market research and competitive intelligence provider, says that North America is projected to maintain hegemony in terms of botulinum toxin sales over the decade (2024 to 2034).
Expanding geriatric population around the world and growing focus on aesthetic appearance are projected to act as major catalysts for botulinum toxin sales over the next 10 years. The increasing influence of social media is bolstering the importance of looking perfect. This coupled with the growing availability of cosmetic surgeries is estimated to create a highly opportune scenario for botulinum toxin companies.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9303
In contrast, lack of favorable reimbursements for treatments utilizing botulinum toxin and the growing availability of counterfeit products that have significant side effects are predicted to hamper botulinum toxin sales in the future. Botulinum toxin manufacturing companies are focusing on collaborating with health insurance companies to improve the reimbursement scenario all over the world.
| Report Attribute | Details |
| Value Projection (2034) | US$ 13.14 Billion |
| Growth Rate (2024-2034) | 6.8% CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 84 Tables |
| No. of Figures | 112 Figures |
Key Takeaways from Market Study
-
The global botulinum toxin market is estimated at US$ 6.83 billion in 2024.
-
Demand for botulinum toxin is set to rise at a CAGR of 6.8% from 2024 to 2034.
-
The market is forecasted to attain a valuation of US$ 13.14 billion by 2034-end.
-
Increasing geriatric population, rising availability of minimally invasive cosmetic surgeries, increasing demand for anti-aging products, and growing willingness of consumers to spend on aesthetic wellness are key market drivers.
-
Sales of botulinum toxin in the United States are set to increase at 7.1% CAGR over the next 10 years.
-
Botulinum toxin sales in Latin America are predicted to reach US$ 530 million by 2034.
-
Type A botulinum toxin is forecasted to account for 99.3% of global market revenue in 2024.
“Growing use of botulinum toxin in the development of therapeutics is projected to offer attractive business opportunities for botulinum toxin companies in the future,” says a Fact.MR analyst